Role of the aging vasculature and Erb B‐2 signaling in epidermal growth factor‐dependent intravasion of breast carcinoma cells
Abstract
BACKGROUND: The risks for developing breast carcinoma and dying from the disease increase with age. Mortality from breast carcinoma usually is due to metastatic disease. Metastatic cells are able to invade into the vascular tissue in a growth factor‐dependent manner. Because breast carcinoma mortality increases with age, examination of breast carcinoma interactions with young and aged endothelial cells is essential.METHODS: We studied a series of breast epithelial cells (HMT‐3522 cells) that exhibited either noninvasive characteristics (S‐1 cells) or epidermal growth factor (EGF)‐dependent invasive characteristics (T4‐2 cells).RESULTS: Increased invasion of HMT‐3522 cells was observed across an aged rat brain microvascular endothelial cell (BMEC) monolayer that was isolated from aged rats (24 months) compared with young rats (age 1 month). This increased invasion was inhibited by the specific EGF receptor inhibitor, AG1478, and by the Erb B‐2‐specific inhibitor, AG825. To analyze further the contribution of Erb B‐2 to the EGF‐dependent invasion of HMT‐3522 cells, T4‐2 cells were treated with the Erb B‐2‐specific therapeutic antibody trastuzumab and with the specific inhibitor AG825 and were then assayed for invasion. Both inhibitors led to a significant decrease in EGF‐dependent invasion. Erb B‐2 expression was found to be elevated in T4‐2 cells (≈ 5‐fold higher) compared with S‐1 cells. However, treatment of T4‐2 cells with the specific Erb B‐2 inhibitor, AG825, failed to inhibit EGF‐mediated signaling to phosphatidylinositol 3‐kinase or extracellular‐regulated kinases 1 and 2.CONCLUSIONS: The current study findings indicate that aging of endothelium may contribute to the invasive phenotype of breast carcinoma cells and that “cross‐talk” between Erb B‐2 and EGF receptor is required for the intravasion of these cells into the surrounding vasculature. Cancer 2004. © 2004 American Cancer Society.Keywords
This publication has 18 references indexed in Scilit:
- Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial CellsJournal of Biological Chemistry, 2002
- The Invasive Phenotype in HMT-3522 Cells Requires Increased EGF Receptor Signaling Through Both PI 3-Kinase and ERK 1,2 PathwaysCell Communication & Adhesion, 2002
- ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial aciniNature Cell Biology, 2001
- The EGF receptor family as targets for cancer therapyOncogene, 2000
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial CellsJournal of Biological Chemistry, 2000
- Motility and invasion are differentially modulated by Rho family GTPasesOncogene, 2000
- Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biologyProceedings of the National Academy of Sciences, 1998
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Cytogenetic analysis of in vitro karyotype evolution in a cell line established from nonmalignant human mammary epitheliumCancer Genetics and Cytogenetics, 1989